Endocrine Flashcards
(152 cards)
Define type 1 diabetes
A metabolic, autoimmune disorder of multiple aetiology characterised by hyperglycaemia with disturbance of carbohydrate, protein and fat metabolism, resulting from defects in insulin secretion, insulin action or both
What is the aetiology of T1 diabetes?
- Combination of genetic and environmental factors
- Genetic: HLA-DR3 and HLA-DR4
- Environmental RFs: viral infection, Vit. D infection, cows milk, obesity
- This leads to autoimmune destruction of Islet of Langerhan B-cells in the pancreas
- Type IV hypersensitivity (cell-mediated immune response)
What is the clinical presentation of T1DM?
- Polyuria: frequent passing of large amounts of urine
- Polydipsia: excessive thirst
- Polyphagia: excessive eating/appetite
- Glycosuria: glucose in urine
What is the pathogenesis of T1DM?
- Autoimmune destruction of the insulin-producing B-cells in Islets of Langerhans in pancreas
- Presence of Islet cell antibodies causing accumulation of lymphocytic infiltration and destruction of B-cells
- Type IV hypersensitivity (cell-mediated immune response targeting Islet of Langerhan B-cells)
- As B-cell mass declines, insulin secretion also declines until insufficient insulin to maintain normal blood glucose
- Insulin is needed for glucose to enter cells, so if it can’t, it remains in the blood causing hyperglycaemia
- Symptoms appear after 90% of B-cells are destroyed (hyperglycaemia)
- Severe insulin deficiency
What is the WHO diagnostic criteria for Diabetes?
Fasting Plasma Glucose
- Normal: <7 Diabetes: >7
Random/2-hr Plasma Glucose
Normal: <7.8 Diabetes: >11.1
- One abnormal value is diagnostic if symptomatic
- 2 abnormal values is diagnostic if asymptomatic
HbA1c: average glucose over 2-3 months
- Normal: <42mmol/mol
- Pre-diabetic: 42-47mmol/mol
- Diabetic: >48mmol/mol or 6.5%
- Primary test for T2DM, not for T1DM
What is HbA1c and what are the pitfalls to using this value?
- This is haemoglobin bound to glucose
- The value represents average plasma glucose over 2-3 months
- Primary test for T2DM and can be used in conjunction with other tests for T1DM
Pitfall: it doesn’t respond quickly to changes in glucose levels
- Removal of the pancreas would result in diabetes but HbA1c would be normal
- T1DM can develop rapidly (esp. in children), so HbA1c may be misleading
How is T1DM diagnosed?
Plasma glucose: Fasting >7, 2-hr >11.1
- One abnormal value with symptoms or 2 abnormal values if asymptomatic on separate occassions
Symptoms
- Polyuria, polydipsia, polyphagia, glycosuria
PLASMA Ketone testing +/- bicarbonate
- 0.6-1.5mmol/l: indicates development of a problem
- >1.5mmol/l in presence of hyperglycaemia indicates high risk of DKA
Pancreatic/Islet cell autoantibodies (GAD ab)
- Associated with autoimmune process associated with T1DM
C-Peptide Testing
- C-peptide secreted in equimolar concentrations to insulin
- Marker of endogenous insulin secretion
- Differentiates between T1 and T2: will be low in T1 and normal/high in T2
How is T1DM managed?
- Insulin replacement therapy
- Glucose/Ketone monitoring
- CHO counting and education
- Supported self-management
What are the main types of insulin replacement used for T1DM?
What are the target glucose levels?
Basal bolus:
- Long-acting insulin analogue in morning with short-acting analogue taken at mealtimes
- More flexibility with mealtimes, content of meals and structure of day (work/exercise) howevere more injections
BM Fixed regime:
- Mixture of short-acting and inter-mediate acting taken twice daily (breakfast and dinner)
- Very structured (only 2 injections) but much less flexibility with day
- At some points, there’ll be excess insulin and there’s a risk of hypoglycaemia
target glucose level: HbA1c <53mmol/l
What is the function of insulin?
- Increases cellular glucose uptake
- Stimulates glycogenesis, enourages DNA synthesis and promotes GH release
What education is required for newly diagnosed T1DM patients?
- Insulin administration
- Glucose/Ketone monitoring
- Sick dat rules: may need more insulin when ill, and never stop long-acting insulin
- Detection and management of hypoglycaemia
- Driving regulations
- Exercise and diet (esp alcohol)
- Micro and macrovascular complications
Compare T1DM and T2DM
T1DM: immune pathogenesis and severe insulin deficiency
T2DM: combination of insulin resistance and partial insulin deficiency
Age - T1DM: <35, T2DM: >35
Weight: T1 lean, T2 obese/overweight
Symptom duration: T1 weeks, T2 months/years
Seasonal onset: T1 yes, T2 no
Hereditary: T1 HLA-DR3/4, T2 none
Pathogenesis: T1 autoimmune, T2 no immune disturbance
Ketonuria/aemia/Acidosis: T1 common, T2 uncommon
Clinical:
- T1 insulin deficiency +/- ketoacidosis, dependent on insulin
- T2 partial insulin deficiency +/- hyperosmolar state, may need insulin
Biochem:
- T1: C-peptide negative, usually GAD ab +ve
- T2: C-peptide elevated, GAD ab -ve
Briedly describe the less common types of diabetes and how they might be distinguished from each other
LADA (Latent Autoimmune Diabetes of the Adult)
- Slow burner T1DM ie. develops later on, will have autoantibodies
- Not absolute insulin deficiency
Pancreatic Diabetes
- Caused by mutation of a single gene ie. monogenic
- Other aetiology: pancreatectomy, pancreatitis
- Also have loss of alpha cells (produce glucagon) therefore higher risk of hypoglycaemia
- Main features: <25yrs, familial
- Managed by diet, oral antihyperglycaemic agents, insulin
MODY (Maturity Onset Diabetes of the Young)
- Mongenic
- Features: <25yrs, normal weight
- Normal C-peptide and -ve autoantibodies
Define T2DM
Chronic, progressive metabolic disorder characterised by hyperglycaemia, insulin resistance and partial insulin deficiency
What is the pathogenesis for T2DM?
- Combination of insulin resistance and partial insulin deficiency
- With a high-glucose diet, the body is able to maintain normal glycaemia by producing more insulin
- The body then develops insluin resistance leading to impaired glucsoe tolerance in a hyperinsulinaemic state
- Insulin production increases until eventually pancreas can’t accomodate from hyperinsulinaemia (with regards to insulin resistance)
- Therefore, insulin levels fall to develop partial insulin deficiency, the threshold for diabetes
What are the early and late signs of hypoglycaemia?
Early:
- Hunger, tingling lips, palpatations
- sweating, fatigue, dizziness, shaking/trembling
- Irritable, pale
Late:
- Weakness, blurred vision
- Difficulty concentrating, confusion
- Seem drunk (slurred speech, unusual behaviour)
- Seizures, syncope
What are the risk factors for T2DM?
- >40yrs (or >25 for South Asian population)
- 1st degree relative with T2DM
- Overweight or obese
- South Asian, Chinese, African carribean or black African origin
What are the symptoms of T2DM?
- Polyuria
- Polydipsia
- Polyphagia
- Glycosuria
- Fatigue
- Weight loss
- Blurred vision or wounds taking longer to heal
How is T2DM diagnosed?
HbA1c
- A result of <6.5% / 48mmol/l
General DM diagnosis includes fasting plasma glucose >7.0 and 2-hr post feeding plasma glucose >11.1
- One of these with symptoms diagnostic
- Need both and on two separate occassions to be diagnostic if asymptomatic
What are the goals for treatment in T2DM?
- Reducing rates of microvascular complications ie. complications affecting small blood vessels: Retinopathy, nephropathy, neuropathy, foot disease
- Cardiovascular safety: minimum requirement
- Reducing rates of macrovascular complications: MI, stroke, HF, peripheral vascular disease
- Prescribe treatment that is in favour of improving outcome (prognosis): need to balance symptom control and prognosis with side effects and adherence
What are the complications of T2DM?
Microvascular complications:
- Retinopathy: glaucoma, cataracts
- Nephropathy: inc. BP and overworked by inc. glucocse
- Neuropathy: pain +/or numbness
- Diabetic foot: undetected foot wounds lead to infections and gangrene
- Impaired wound healing, impaired bision
Macrovascular complications:
- Heart: MI, HF
- Brain: stroke, cerebrovascular disease, cognitive impairment
- Extremeties: peripheral vascular disease
What are the biomedical targets for treatment of T2DM?
HbA1c: around 7% (individualised) eg. patient with hypoglycaemic unawareness may have a target of 8/8.5%
BP: <130/80
- ACEi (ramipril) or ARB, calcium channel blocker, thiazide diuretic
Cholesterol: statin if >40yrs
Normal body weight / weight reduction
List the treatment ladder for T2DM
Very first line: lifestyle modifications (diet and exercise) especially if early on and aymptomatic
1st line (1 agent): metformin or sulphonylureas (SU, Gliclazide)
2nd line (2 agents): add SU (gliclazide), SGLT-2 inhibitor (flozin), DPP-4 inhibitor (gliptin) or glitazone
3rd line (3 agents): add SU, SGLT-2 inhibitor, DPP-4 inhibitor or glitazone OR injectable therapy (GLP-1 agonist or insulin)
4th line (4 agents): add another from the list above
What is the class, indication and action of metformin?
Class: Biguanide
Indication: T2DM alonside exercise and diet
- Metabolic and reproductive abnormalities associated with polycystic ovarian syndrome
Action:
- Increases the activity of AMP-dependent protein kinase (AMPK)
- This inhibits gluconeogenesis (hepatic glucose production)
- Reduces insulin resistance
- Increases peripheral insulin sensitivity in mucle, increasing glucose uptake and utilisation